SpotitEarly (Series A)

Funding Details
Awarder
Inbox
Date Award
May 15, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$20,300,000

Company Info
Founding Year
2020
Traction
The breath test has demonstrated 94% accuracy in detecting multiple cancer types in a large-scale clinical trial of 1,200 people.
Company Description
SpotitEarly is a cancer-treatment-focused Israeli medtech startup.
Market
Cancer Detection
Location
United States

Links